Zobrazeno 1 - 10
of 52
pro vyhledávání: '"LeAnn B. Norris"'
Publikováno v:
Cancer Medicine, Vol 8, Iss 5, Pp 2233-2240 (2019)
Abstract Chronic lymphocytic leukemia (CLL) patients are at increased risk for major hemorrhage (MH). We examined incidence of and risk factors for MH in CLL patients before introduction of newer CLL therapies such as ibrutinib, which includes bleedi
Externí odkaz:
https://doaj.org/article/da2869cea09247beb4d185946867fc53
Autor:
James O. Armitage, Shamia Hoque, Laura Rose Bobolts, LeAnn B. Norris, Sumimasa Nagai, Chadi Nabhan, Oliver Sartor, Anuhya Kommalapati, Robert C. Kane, Carlo DeAngelis, Paul R. Yarnold, Charles L. Bennett, Joshua Riente, Dennis W. Raisch, Brian Chen, Paul Ray, Ashley Caitlin Godwin, Stefano Luminari, William J. M. Hrushesky, Bryan L. Love, Bartlett J. Witherspoon, Kevin B. Knopf, Y. Tony Yang, Sri Harsha Tella
Publikováno v:
The Oncologist. 24:537-548
Biosimilar filgrastims are primarily indicated for chemotherapy-induced neutropenia prevention. They are less expensive formulations of branded filgrastim, and biosimilar filgrastim was the first biosimilar oncology drug administered in European Unio
Publikováno v:
Pharmacotherapy
Hepatitis B virus (HBV) is a global disease with significant morbidity and mortality. Worldwide, an estimated 257 million people are chronically infected with HBV, defined as having a positive hepatitis B surface antigen, but millions more have prior
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5a6729518396103b2f58933853b07de
https://europepmc.org/articles/PMC6893091/
https://europepmc.org/articles/PMC6893091/
Autor:
Paul Ray, LeAnn B. Norris, Paul R. Yarnold, William J. M. Hrushesky, Charles L. Bennett, Joseph R. Berger, Robert C. Kane, Oliver Sartor, Rachel A. Sabol, Peter Georgantopoulos, Dennis W. Raisch, Laura Rose Bobolts, Akida Lebby, Zaina P. Qureshi, Virginia Noxon
Publikováno v:
Cancer Medicine
A 43‐year‐old female with multiple sclerosis developed urethral melanoma. The only potential risk factor was treatment with natalizumab, a humanized monoclonal antibody against α4 integrins. To investigate the risk‐exposure relationship, we re
Autor:
Norman Marks, Charles L. Bennett, Brian Chen, LeAnn B. Norris, Dawn L. Hershman, Richard Schulz, John Bian
Publikováno v:
Journal of Clinical Oncology. 35:1945-1951
Purpose In March 2007, a US Food and Drug Administration boxed warning was issued for erythropoietin-stimulating agents (ESAs) regarding serious adverse events, such as venous thromboembolism (VTE). We evaluated the US Food and Drug Administration’
Autor:
Paul R. Yarnold, Dennis J. Cotter, Zaina P. Qureshi, Akida Lebby, William J. M. Hrushesky, Neset Hikmet, LeAnn B. Norris, Virginia Noxon, Brian J. Chen, Charles L. Bennett, Michael Dickson, Y. Tony Yang, Benjamin Schooley, Mae Thamer, Kevin B. Knopf
Publikováno v:
Journal of Oncology Practice. 13:e562-e573
Purpose: The US Food and Drug Administration (FDA) has approved epoetin and darbepoetin for chemotherapy-induced anemia (CIA). Approved epoetin and darbepoetin dosing schedules were three times per week and weekly, respectively, although off-label, l
Autor:
Oliver Sartor, Peter Georgantopoulos, Charles L. Bennett, William J. M. Hrushesky, LeAnn B. Norris, Dennis W. Raisch, Brian Chen, Akida Lebby, Robert C. Kane, Sumimasa Nagai, Terhi Hermanson, Y. Tony Yang, Laura R. Bobolts, Samuel Kessler, Joshua J. Riente, Zaina P. Qureshi, James O. Armitage
Publikováno v:
The Lancet Oncology. 17:e493-e501
Although the availability of generic oncology drugs allows access to contemporary care and reduces costs, there is international variability in the safety of this class of drugs. In this Series paper, we review clinical, policy, safety, and regulator
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 9
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 9
Autor:
Joseph R. Berger, Charles L. Bennett, LeAnn B. Norris, James O. Armitage, Dennis W. Raisch, Peter Georgantopoulos, William J. M. Hrushesky, Oliver Sartor, Kenneth R. Carson
Publikováno v:
British Journal of Haematology. 180:301-304